about
High-mobility group protein HMGB2 regulates human erythroid differentiation through trans-activation of GFI1B transcriptionIL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesisPUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells.A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB.Viability and stress protection of chronic lymphoid leukemia cells involves overactivation of mitochondrial phosphoSTAT3Ser727.STAT5 and Oct-1 form a stable complex that modulates cyclin D1 expression.Control of Pim2 kinase stability and expression in transformed human haematopoietic cellsHuman and simian immunodeficiency viruses deregulate early hematopoiesis through a Nef/PPARgamma/STAT5 signaling pathway in macaquesInterleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathway.A short Gfi-1B isoform controls erythroid differentiation by recruiting the LSD1-CoREST complex through the dimethylation of its SNAG domain.STAT1-dependent IgG cell-surface expression in a human B cell line derived from a STAT1-deficient patient.Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma.Selective modification of eukaryotic initiation factor 4F (eIF4F) at the onset of cell differentiation: recruitment of eIF4GII and long-lasting phosphorylation of eIF4E.BCR-ABL and constitutively active erythropoietin receptor (cEpoR) activate distinct mechanisms for growth factor-independence and inhibition of apoptosis in Ba/F3 cell line.Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascadeDifferential contributions of STAT5A and STAT5B to stress protection and tyrosine kinase inhibitor resistance of chronic myeloid leukemia stem/progenitor cells.Forced expression of p21 in GPIIb-p21 transgenic mice induces abnormalities in the proliferation of erythroid and megakaryocyte progenitors and primitive hematopoietic cells.Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells.BCR-ABL induces opposite phenotypes in murine ES cells according to STAT3 activation levels.[STAT5, a new therapeutic target against the relapse of chronic myelogenous leukemia?].[Negative regulation of the JAK/STAT: pathway implication in tumorigenesis].STAT6 activity is regulated by SOCS-1 and modulates BCL-XL expression in primary mediastinal B-cell lymphoma.STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy?Vers un nouveau rôle du récepteur PPAR-γ dans le syndrome d’immunodéficience acquise et les hémopathies chez l’hommeErratum: Viability and stress protection of chronic lymphoid leukemia cells involves overactivation of mitochondrial phosphoSTAT3Ser727Molecular study of the hematopoietic zinc finger gene in three unrelated families with gray platelet syndromeIFN Regulatory Factor-2 Cooperates with STAT1 to Regulate Transporter Associated with Antigen Processing-1 Promoter ActivityCell swelling activates STAT1 and STAT3 proteins in cultured rat hepatocytesFOXO1 transcription factor plays a key role in T cell-HIV-1 interaction.
P50
Q24336301-528DDE7A-BA52-48FF-9BD3-B8F2BDCFB131Q24604346-D2A3411E-DD55-44D8-B1B7-0FC05E706BA4Q33675855-47DB2877-9EB5-4821-A61F-58DB967EA658Q33870579-9D86AF42-A014-406E-84F5-412167A4A7B9Q34541525-CDF25021-A3A5-4634-9409-CA4FAEC9A7C1Q34985773-D18E0514-8A42-42BE-834A-FEB148D3BA4CQ36353641-00A10101-5365-45D4-8C85-34E9BFA64950Q36570464-C1D51FF9-22EF-4476-80E0-A0952B974744Q38305038-277956A7-63FC-428C-BA8B-F8ED5450BD05Q39383466-17F89E63-3D15-4581-84A6-F5A541DFF94DQ39732610-591155F0-C18A-4BF1-9E7B-D6C09C1546D3Q40573622-ACB5F9DF-5BC7-47A7-8EB3-EDFC3AB9E9E1Q40886501-DE0F63CD-A25E-4F33-8726-04316D880FEFQ41062954-1C0D1FA9-4613-4C79-9908-88D52002F587Q42433996-4911893C-332C-4B59-B169-B894D55EFF3FQ42520569-F473400D-4D8F-4FEC-9144-0C3278FFF8D3Q44210712-99596B84-F351-4F16-B12A-E59B47D9A987Q44488212-538C9B38-8958-4F26-8AA3-1AC11DD67E85Q46331706-4F64C708-4B38-4374-AD7E-25AD5B80C49AQ46450278-92CE3DEE-5B43-4F70-95AE-73378B722C68Q46788255-AD40BABE-C682-47E5-81D3-5668A3BB14BEQ53485414-E4516E3C-AFE9-490B-BD05-1B4C8363FCA3Q54427862-F4EFEF7C-2890-46CF-AA4E-B3CA91BFBD9DQ56947073-EE51568B-1DB0-44D0-8C4C-60D4662BE57FQ62069982-1C7120A2-04E4-47F5-967C-8198CDB735DEQ62070069-426D27CD-00CA-4FCA-A9B5-357BFB3A861FQ62070071-74CAB054-614A-440D-ACA8-0BB88CD114FDQ62070083-B13FA3AD-AF9B-4CE0-B60D-CA72E0C20027Q64921659-3B5E75F9-CAE1-4EAC-82AB-449D9B6FF7A7
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Isabelle Dusanter-Fourt
@ast
Isabelle Dusanter-Fourt
@en
Isabelle Dusanter-Fourt
@es
Isabelle Dusanter-Fourt
@nl
Isabelle Dusanter-Fourt
@sl
type
label
Isabelle Dusanter-Fourt
@ast
Isabelle Dusanter-Fourt
@en
Isabelle Dusanter-Fourt
@es
Isabelle Dusanter-Fourt
@nl
Isabelle Dusanter-Fourt
@sl
prefLabel
Isabelle Dusanter-Fourt
@ast
Isabelle Dusanter-Fourt
@en
Isabelle Dusanter-Fourt
@es
Isabelle Dusanter-Fourt
@nl
Isabelle Dusanter-Fourt
@sl
P1053
P-4558-2017
P106
P21
P31
P3829
P496
0000-0002-9286-1021